Design of an innovative nanovehicle to enhance brain permeability of a novel 5-HT6 receptor antagonist
An innovative nanovehicle based on lipid nanocapsules (LNC) was designed to facilitate the passage of a new 5-HT6 receptor antagonist, namely PUC-10, through the blood-brain barrier. PUC-10 is a new synthetic N-arylsulfonylindole that has demonstrated potent 5-HT6 receptor antagonist activity, but i...
Saved in:
Main Authors: | María Javiera Alvarez-Figueroa (Author), Francisco Nuñez-Navarro (Author), Gonzalo Recabarren-Gajardo (Author), José Vicente González-Aramundiz (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dextran Nanocapsules with <i>ω</i>-3 in Their Nucleus: An Innovative Nanosystem for Imiquimod Transdermal Delivery
by: Gisela F. Carreño, et al.
Published: (2022) -
Effects of 5‐HT₃ receptor antagonists on cisplatin‐induced kidney injury
by: Mitsuhiro Goda, et al.
Published: (2021) -
Enhancing cancer therapy: advanced nanovehicle delivery systems for oridonin
by: Yilin Su, et al.
Published: (2024) -
Novel <i>N</i>-Arylsulfonylindoles Targeted as Ligands of the 5-HT<sub>6</sub> Receptor. Insights on the Influence of C-5 Substitution on Ligand Affinity
by: Loreto Arrieta-Rodríguez, et al.
Published: (2021) -
Antiemetic Activity of FK1052, a 5-HT3- and 5-HT4-Receptor Antagonist, in Suncus murinus and Ferrets
by: Hiroe Nakayama, et al.
Published: (2005)